El Prof. MD Zafer Gulbas es especialista en oncología médica y hematología, director de oncología médica en el Centro Médico Anadolu y fundador del Centro de Trasplante de Médula Ósea en Anadolu. Es un hematólogo-oncólogo altamente calificado, especializado en trasplante de médula ósea, con educación de la Facultad de Medicina de la Universidad de Hacettepe, la Facultad de Medicina de la Universidad de Anadolu, el Centro de Enfermedades Pulmonares y Cirugía Torácica Atatürk, el Centro Médico Hadassah, el Centro de Investigación del Cáncer Fred Hutchinson, el Centro de Investigación del Cáncer MDAnderson. y el Hospital Princess Margaret de la Universidad de Toronto.
El doctor se graduó de la Escuela de Medicina de Hacettepe en 1985 y se convirtió en Especialista en Medicina Interna en la Universidad de Ege en 1990. Para profundizar su experiencia, el doctor se especializó en hematología y completó un doctorado en la Escuela de Medicina de Mie en Japón en 1995. Para 1997, el doctor había avanzado a Profesor Asistente y luego Profesor de Hematología en la Universidad de Ege. En 2003, el doctor continuó como Profesor de Hematología en la Universidad Técnica de Karadeniz. Con más de 65 artículos científicos, 112 documentos de reuniones y 34 presentaciones en conferencias, el doctor es reconocido por sus contribuciones a la hematología y el trasplante de médula ósea.<\/p>
La Dra. Betül Tavil es profesora de hematología y oncología pediátricas, experta de clase mundial en trasplante de médula ósea para niños.
Por qué los pacientes confían en la Dra. Tavil:
Turkish hematology centers offer comprehensive treatments for hemolytic anemia, including bone marrow transplants, immunosuppressive therapy, and surgical splenectomy. Specialized units at JCI-accredited clinics like Anadolu Medical Center and Medipol Mega provide definitive curative options for inherited conditions like sickle cell and thalassemia through advanced stem cell transplantation.
Bookimed Expert Insight: Turkey stands out for scale, with units like Medipol Mega and Emsey Hospital operating 45-bed bone marrow transplant centers. This high capacity allows Professor Dr. Zafer Gulbas at Anadolu to maintain an 81% success rate for autologous transplants. Patients often choose these centers because they combine high-volume experience with direct affiliations to major US medical institutions.
Patient Consensus: Patients emphasize the need for a precise hematology workup first, as the specific cause determines whether they receive steroids or a transfusion. Many note that while transfusions bring immediate relief, consistent follow-up testing is essential because the underlying hemolysis may still be active.
Turkish hospitals utilize high-resolution hemoglobin electrophoresis and direct antiglobulin tests to identify hemolytic anemia types. JCI-accredited centers in Istanbul perform advanced flow cytometry and genetic panels to distinguish between inherited and acquired disorders. Diagnosis often involves board-certified hematologists from institutions like Anadolu Medical Center.
Bookimed Expert Insight: While many general hospitals provide basic blood counts, centers like Anadolu Medical Center and Medipol Mega offer specialized Bone Marrow Transplant units and flow cytometry. These facilities handle a massive volume of complex blood disorders annually. Choosing a clinic with an integrated flow cytometry lab ensures faster results for rare hemolytic subtypes.
Patient Consensus: Patients emphasize the importance of requesting a complete hemolysis panel early. They also note that recent blood transfusions can sometimes interfere with testing accuracy.
Bone marrow transplant (BMT) is used in Turkey as a curative treatment for severe hemolytic anemias. Specialists perform this procedure for inherited conditions like thalassemia major and sickle cell disease. JCI-accredited centers in Istanbul provide these complex hematopoietic stem cell transplants for children and adults.
Bookimed Expert Insight: While many view BMT as a general procedure, Turkish centers like Medipol Mega and Emsey Hospital offer specialized pediatric-focused units. This specialization is critical because inherited hemolytic anemias are often diagnosed in childhood. Choosing a center with a large bed capacity typically ensures shorter waiting times for life-saving donor matching.
Patient Consensus: Patients emphasize that a precise subtype diagnosis is necessary before considering a transplant. They mention that Turkish hematologists focus on BMT as a last-resort but potentially curative option for severe disease.